Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 46

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 46
---
 ESPP is set forth on Form 10-Q filed on August 7, 2019, and the full text of Amendment No. 2 to the 2016 ESPP is set forth on Form 8-K filed on June 9, 2023. The following description of certain features of the 2016 ESPP is qualified in its entirety by reference to the full text of the 2016 ESPP and Amendments No. 1, No. 2 and No. 3 thereto.

Summary of the 2016 ESPP

Administration.The 2016 ESPP is administered by the Board or, to the extent administration of the 2016 ESPP is delegated by the Board to the compensation committee, by the compensation committee. References in this summary to the “Administrator” mean the Board or, in the event of such delegation, the compensation committee. The Administrator may delegate to such employees or other persons as it determines such ministerial tasks as it deems appropriate. The Administrator has the power to interpret the 2016 ESPP and the terms of the options granted under the 2016 ESPP and to adopt such rules for the administration, interpretation, and application of the 2016 ESPP as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon all participants, the Company and all other interested persons.

Shares subject to 2016 ESPP.Subject to adjustment upon changes in capitalization of the Company as described below, the maximum number of shares of the Company’s common stock available for issuance under the 2016 ESPP is 1,700,000 shares, which includes the share increase described above. If any option granted under the 2016 ESPP for any reason terminates without having been exercised, the shares of the Company’s common stock not purchased under such option will again become available for issuance under the 2016 ESPP. The shares of the Company’s common stock available for issuance under the 2016 ESPP may be unissued shares or reacquired shares, bought on the market or otherwise. On April 22, 2025, the closing price of a share of our common stock was $59.31.

<div align='center'>26</div>

Eligibility. Participation in the 2016 ESPP will be limited to employees of the Company and its designated subsidiaries whose customary employment is for at least 20 hours per week